Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study
- PMID: 18539224
- DOI: 10.1016/S0140-6736(08)60834-X
Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study
Erratum in
- Lancet. 2008 Dec 13;372(9655):2022
Abstract
Background: Results of several studies published since 1999 suggest that primary hyperaldosteronism (also known as Conn's syndrome) affects more than 10% of people with hypertension; however, such a high prevalence has also been disputed. Experts generally agree that resistant hypertension has the highest prevalence of primary hyperaldosteronism, on the basis of small studies. We aimed to assess the prevalence of primary hyperaldosteronism in a large group of patients with resistant hypertension.
Methods: Patients with resistant hypertension (blood pressure >140/90 mm Hg despite a three drug regimen, including a diuretic) who attended our outpatient clinic were assessed for primary hyperaldosteronism. Serum aldosterone and plasma renin activity were determined and their ratio was calculated. Patients with a positive test (ratio >65.16 and aldosterone concentrations >416 pmol/L) underwent salt suppression tests with intravenous saline and fludrocortisone. Diagnosis of primary hyperaldosteronism was further confirmed by the response to treatment with spironolactone.
Findings: Over 20 years, we studied 1616 patients with resistant hypertension. 338 patients (20.9%) had a ratio of more than 65.16 and aldosterone concentrations of more than 416 pmol/L. On the basis of salt suppression tests, 182 (11.3%) patients had primary hyperaldosteronism, and response to spironolactone treatment further confirmed this diagnosis. Hypokalaemia was seen only in 83 patients with primary hyperaldosteronism (45.6%).
Interpretation: Although the prevalence of primary hyperaldosteronism in patients with resistant hypertension was high, it was substantially lower than previously reported. On the basis of this finding, we could assume that the prevalence of primary hyperaldosteronism in the general unselected hypertensive population is much lower than currently reported. Thus, the notion of an epidemic of primary hyperaldosteronism is not supported.
Comment in
-
Primary hyperaldosteronism in patients with resistant hypertension may be less prevalent than previously reported: evidence against an epidemic.J Clin Hypertens (Greenwich). 2008 Aug;10(8):655-7. doi: 10.1111/j.1751-7176.2008.08058.x. J Clin Hypertens (Greenwich). 2008. PMID: 18780479 Free PMC article. No abstract available.
Similar articles
-
Normokalemic hyperaldosteronism in patients with resistant hypertension.Isr Med Assoc J. 2002 Jan;4(1):17-20. Isr Med Assoc J. 2002. PMID: 11802302
-
Prevalence of primary hyperaldosteronism assessed by aldosterone/renin ratio and spironolactone testing.Clin Med (Lond). 2005 Jan-Feb;5(1):55-60. doi: 10.7861/clinmedicine.5-1-55. Clin Med (Lond). 2005. PMID: 15745200 Free PMC article.
-
The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio.Circulation. 2007 Jul 17;116(3):268-75. doi: 10.1161/CIRCULATIONAHA.107.690396. Epub 2007 Jul 2. Circulation. 2007. PMID: 17606839 Clinical Trial.
-
Primary aldosteronism: renaissance of a syndrome.Clin Endocrinol (Oxf). 2007 May;66(5):607-18. doi: 10.1111/j.1365-2265.2007.02775.x. Clin Endocrinol (Oxf). 2007. PMID: 17492946 Review.
-
Hyperaldosteronism as a common cause of resistant hypertension.Annu Rev Med. 2013;64:233-47. doi: 10.1146/annurev-med-042711-135929. Epub 2012 Oct 22. Annu Rev Med. 2013. PMID: 23092384 Review.
Cited by
-
Cutoff Values of Aldosterone and the Aldosterone-Renin Ratio for Predicting Primary Aldosteronism in Patients with Resistant Hypertension: A Real-Life Study.J Cardiovasc Dev Dis. 2024 Sep 27;11(10):299. doi: 10.3390/jcdd11100299. J Cardiovasc Dev Dis. 2024. PMID: 39452270 Free PMC article.
-
Primary and "Pre-Primary" Aldosteronism in Resistant Hypertension: A Practical, Pragmatic, and Prudent Approach in Resource-Limited Milieu.Cureus. 2024 Oct 22;16(10):e72161. doi: 10.7759/cureus.72161. eCollection 2024 Oct. Cureus. 2024. PMID: 39445045 Free PMC article.
-
Predicting the resolution of hypertension following adrenalectomy in primary aldosteronism: Controversies and unresolved issues a narrative review.Langenbecks Arch Surg. 2024 Oct 1;409(1):295. doi: 10.1007/s00423-024-03486-7. Langenbecks Arch Surg. 2024. PMID: 39354235 Review.
-
Utility of Adrenal Vein Sampling With and Without Ultra-Low Dose ACTH Infusion in the Diagnostic Evaluation of Primary Aldosteronism.Endocrinol Diabetes Metab. 2024 Sep;7(5):e70001. doi: 10.1002/edm2.70001. Endocrinol Diabetes Metab. 2024. PMID: 39207956 Free PMC article.
-
'Essential' arterial hypertension: time for a paradigm change.J Hypertens. 2024 Aug 1;42(8):1298-1304. doi: 10.1097/HJH.0000000000003767. Epub 2024 May 8. J Hypertens. 2024. PMID: 38748508 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
